Why the study?
DJ-1 protects against ischemia-reperfusion injury and is increasingly recognized in cardiovascular pathophysiology, prompting a review of current knowledge, gaps, and original data on its role following cardiac and vascular surgery.
Is increased DJ-1 expression associated with antiapoptotic and anti-inflammatory markers following cardiac and vascular surgical procedures?
Is increased DJ-1 expression associated with antiapoptotic and anti-inflammatory markers following cardiac and vascular surgical procedures?
DJ-1 may serve as a cytoprotective mechanism and a plausible novel therapeutic target for cardiovascular disease.
May indicate cytoprotective responses post-surgery; leaves open DJ-1 as a therapeutic target pending prospective trials.
DJ-1 was originally identified as an oncogene product while mutations of the gene encoding DJ-1/PARK7 were later associated with a recessive form of Parkinson's disease. Its ubiquitous expression and diversity of function suggest that DJ-1 is also involved in mechanisms outside the central nervous system. In the last decade, the contribution of DJ-1 to the protection from ischemia-reperfusion injury has been recognized and its involvement in the pathophysiology of cardiovascular disease is attracting increasing attention. This review describes the current and gaps in our knowledge of DJ-1, focusing on its role in regulating cardiovascular function. In parallel, we present original data showing an association between increased DJ-1 expression and antiapoptotic and anti-inflammatory markers following cardiac and vascular surgical procedures. Future studies should address DJ-1's role as a plausible novel therapeutic target for cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Tsoporis et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: